Sign In
Buy BETRF
$0.0471
+0.0041 (+9.53%)
At Close: Jun 03, 2026
BetterLife Pharma has a promising pipeline of psychedelic products, a coronavirus nebulizer and AP-001 cream
06:53am, Wednesday, 28'th Apr 2021
Three compelling and differentiated assets Potential coronavirus treatment AP-003's Phase 2 trial to start in 2Q 2021 Management team led by veteran entrepreneur CEO Dr Ahmad Doroudian What BetterLife
BetterLife Pharma adds former FDA Psychiatry Division director as regulatory advisor
09:21am, Thursday, 08'th Apr 2021
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU), a company developing second-generation psychedelics for neuropsychiatric disorders, announced that former Food and Drug Administration (FDA)
Algernon Pharmaceuticals and Betterlife Pharma added to the world's first psychedelic stock ETF
11:46am, Monday, 29'th Mar 2021
Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW) and Betterlife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) have been added to the high-profile Horizons Psychedelic Stock Index ETF (N
Algernon Pharmaceuticals and Betterlife Pharma added to the market's first psychedelic stock index ETF
11:40am, Monday, 29'th Mar 2021
Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW) and Betterlife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) have been added to the high-profile Horizons Psychedelic Stock Index ETF (N
BetterLife Pharma inks research agreement with the University of California San Diego
08:44am, Wednesday, 24'th Mar 2021
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) said it has signed an agreement with the laboratory of Dr Adam L. Halberstadt at the University of California San Diego (UCSD) for TD-0148A pr
BetterLife Enters Into Research Agreement with UCSD for TD-0148A Behavioural Pharmacology Studies
07:45am, Wednesday, 24'th Mar 2021
VANCOUVER, BC / ACCESSWIRE / March 24, 2021 / BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR) / (OTCQB:BETRF) / (FRA:NPAU), an emerging biotech company focused on the development and
BetterLife Pharma says subsidary Altum Pharmaceuticals to conduct coronavirus trial in Chile using its AP-003
10:01am, Thursday, 11'th Mar 2021
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) has announced that its wholly-owned subsidiary Altum Pharmaceuticals has entered into a Letter of Intent with Pontificia Universidad Católica
BetterLife Pharma announces tie-up with Carleton University to study TD-0148A as treatment for depression
09:14am, Monday, 08'th Mar 2021
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) has said it is partnering up with Carleton University in Ottawa to study TD-0148A - a second-generation LSD molecule - to treat depression. Be
BetterLife Pharma hires Eurofins CDMO to manufacture LSD derivative TD-0148A
10:14am, Wednesday, 03'rd Mar 2021
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) has entered an agreement with Eurofins CDMO (contract development and manufacturing organization) Alphora Inc for the manufacturing of its LSD
BetterLife to Present at the Emerging Growth Conference on February 17, 2021
07:00am, Tuesday, 16'th Feb 2021
BetterLife invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference BetterLife invites indi
BetterLife Pharma has a promising pipeline of psychedelic products, a coronavirus nebulizer and AP-001 cream
06:53am, Wednesday, 10'th Feb 2021
Three compelling and differentiated assets Potential coronavirus treatment AP-003's Phase 2 trial to start in 2Q 2021 Management team led by veteran entrepreneur CEO Dr Ahmad Doroudian What BetterLife
BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder
08:30am, Tuesday, 02'nd Feb 2021
Vancouver, Feb. 02, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the develop
BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies
02:00am, Thursday, 28'th Jan 2021
VANCOUVER, Jan. 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the develop
VANCOUVER, Jan. 26, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the develop
BetterLife Selects CRO to Conduct Clinical Trials for AP-003 in COVID-19 Cases in Indonesia
08:30am, Thursday, 21'st Jan 2021
VANCOUVER, Jan. 21, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and c
